SG Americas Securities LLC Cuts Position in iShares Biotechnology ETF $IBB

SG Americas Securities LLC cut its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 3.1% in the 2nd quarter, Holdings Channel reports. The fund owned 14,553 shares of the financial services provider’s stock after selling 460 shares during the quarter. SG Americas Securities LLC’s holdings in iShares Biotechnology ETF were worth $1,841,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in IBB. Signet Financial Management LLC lifted its stake in iShares Biotechnology ETF by 3.3% during the second quarter. Signet Financial Management LLC now owns 2,579 shares of the financial services provider’s stock worth $326,000 after purchasing an additional 83 shares during the last quarter. Optimum Investment Advisors increased its position in shares of iShares Biotechnology ETF by 2.6% during the 2nd quarter. Optimum Investment Advisors now owns 3,345 shares of the financial services provider’s stock valued at $423,000 after purchasing an additional 84 shares during the last quarter. KFG Wealth Management LLC raised its holdings in shares of iShares Biotechnology ETF by 4.8% during the 2nd quarter. KFG Wealth Management LLC now owns 2,444 shares of the financial services provider’s stock valued at $309,000 after buying an additional 112 shares in the last quarter. Westside Investment Management Inc. raised its holdings in shares of iShares Biotechnology ETF by 0.6% during the 2nd quarter. Westside Investment Management Inc. now owns 18,548 shares of the financial services provider’s stock valued at $2,348,000 after buying an additional 118 shares in the last quarter. Finally, QRG Capital Management Inc. lifted its position in iShares Biotechnology ETF by 5.3% in the 2nd quarter. QRG Capital Management Inc. now owns 2,437 shares of the financial services provider’s stock worth $308,000 after buying an additional 123 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.8%

Shares of IBB opened at $165.22 on Thursday. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $167.15. The stock has a 50 day simple moving average of $152.42 and a two-hundred day simple moving average of $137.87.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were given a $0.0828 dividend. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.